David Fleischer

Mar 5, 2025 | healio.com | Richard Gawel |Kristen Dowd |David Fleischer

Key takeaways: The VP250 VIASKIN Peanut patch includes 250 µg of peanut protein. Percentages of children who achieved a 1,000 mg eliciting dose increased. Levels of peanut-specific IgE and IgG4 levels decreased and increased. SAN DIEGO — Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract presented here.

Sep 11, 2024 | medcentral.com | Norbert Goldfield |David Fleischer

At the Democratic National Convention, there was a great deal of talk about the role of neighbors.

Aug 28, 2024 | onlinelibrary.wiley.com | Kaci Pickett-Nairne |Donald Leung |David Fleischer |Liam O'Mahony

CONFLICT OF INTEREST STATEMENT Dr. Fleischer has received research support from ARS Pharmaceuticals and DBV Technologies; serves as an unpaid advisory board member for Food Allergy & Anaphylaxis Connection Team and the National Peanut Board; receives royalties from UpToDate; and received personal fees as a consultant to Aquestive, ARS Pharmaceuticals, Bryn Pharma, DBV Technologies, Genentech, and Nasus outside of the submitted work.

Mar 27, 2024 | healio.com | Richard Gawel |David Fleischer

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: The VP250 patch includes 250 µg of peanut protein. Only two of 87 participants experienced anaphylaxis related to treatment. Most events were mild or moderate local application reactions.

Oct 25, 2023 | mdpi.com | Raanan Shamir |David Fleischer |David Mark

This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReviewby 1,*, 2 and 1 1University of Colorado/Children’s Hospital Colorado: Section of Pediatric Allergy and Clinical Immunology, Aurora, CO 80045, USA2Institute for Gastroenterology, Nutrition and Liver Disease, Schneider Children’s Medical Center of Israel, Faculty of Medicine, Tel Aviv University, Tel Aviv 74071-12-20, Israel*Author to whom correspondence should be addressed.